Bromfenac-d4 Sodium Salt CAS CATO-C4X-200250
| CAS No. | CATO-C4X-200250 |
| Molecular Formula | - |
| Molecular Weight | N/A |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
Chemical Structure
Description
Under current pharmacopoeial and regulatory frameworks, quality-control requirements for this class of reference material explicitly involve the control of targets including Bromfenac-d4 Sodium Salt.
CATO supplies Bromfenac-d4 Sodium Salt (CAS CATO-C4X-200250), a certified reference material (molecular formula C15H7D4BrNO3Na, MW 360.18 g/mol) for analytical method development and quality control.
Bromfenac-d4 Sodium Salt (C15H7D4BrNO3Na) contains deuterium isotope labeling, a salt form, a nitrogen-containing heterocyclic scaffold, an amide group, a hydroxyl group, an ether linkage, bromine substitution. Halogen substitution raises its density and boiling point, its high carbon-to-hydrogen ratio confers good lipid solubility, the carboxyl group imparts weak acidity; these physicochemical properties determine the optimal preparation and storage of its standard solutions. The high carbon-to-hydrogen ratio imparts good lipophilicity, allowing liquid-liquid extraction with non-polar solvents such as n-hexane or ethyl acetate.
Recommended for analytical method development and validation; each product is supplied with a full Certificate of Analysis (COA) ensuring ISO 17034 metrological traceability.
As a certified reference material (CRM), Bromfenac-d4 Sodium Salt meets the metrological traceability requirements of ISO/IEC 17025 laboratories. Batch-to-batch consistency is monitored via control charts to guarantee comparable assigned values across lots.
Physical & Chemical Properties
| Molecular Formula | C15H7D4BrNO3 Na |
| Molecular Weight | 360.18 g/mol |
| Appearance | Pale yellow to yellow crystalline powder. (slight halide-like odor) |
| Purity | 97%+ |
| Storage | Store at 2-8°C, protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in chloroform, dichloromethane, ethyl acetate, DMSO |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 12.5 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Halogen Content | Br-containing |
| Nitrogen Atoms | 1 |
Related Bromfenac Standards
- Bromfenac Impurity 30 (CAS 102414-22-2)
- Bromfenac Sodium Sesquihydrate (CAS 120638-55-3)
- Bromfenac Impurity 30 (CAS 1279501-08-4)
- Bromfenac Impurity 3 (CAS 1391052-54-2)
- Bromfenac Impurity 76 (CAS 1623751-93-8)
- Bromfenac Impurity 33 (CAS 1644279-16-2)
- Bromfenac Impurity N2 (CAS 1798431-98-7)
- Bromfenac N-β-D-Glucoside (CAS 212266-82-5)
Recommended Standards
- 3-Methoxy-1-methylisoquinoline (CAS 23832-77-1)
- N-Methyl-3-pyrrolidin-1-ylpropan-1-amine (CAS 99114-68-8)
- N-Benzyl-N-(pyrrolidin-3-ylmethyl)ethanamine dihydrochloride (CAS 1220027-17-7)
- 5-(3-Methylphenethyl)-1,3,4-thiadiazol-2-amine (CAS 100988-14-5)
- 6-Fluoro-2-piperazin-1-yl-benzooxazole (CAS 1246609-07-3)
- Cyclobutanol (CAS 2919-23-5)
- 54575-49-4 6HK5NKZ8D3 Potassium tri-sec-butylborohydride Potassium tri-sec-butylhydroborate Borate(1-), hydrotris(1-methylpropyl)-, potassium (1:1), (T-4)- Borate(1-), hydrotris(1-methylpropyl)-, potassium, (T-4)- EINECS 259-241-7 UNII-6HK5NKZ8D3 (CAS 54575-49-4)
- Avanafil Impurity 144 (CAS CATO-C4X-1118144)
- 4-((Cyclohexyloxy)methyl)benzaldehyde (CAS 1443348-24-0)
- Semaglutide Impurity 184 (CAS CATO-C4X-2226184)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com